The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Ketogenic Diet in Alzheimer’s Disease
Open accessAbstract
At present, the prevalence of Alzheimer’s disease, a devastating neurodegenerative disorder, is increasing. Although the mechanism of the underlying pathology is not fully uncovered, in the last years, there has been significant progress in its understanding. This includes: Progressive deposition of amyloid β-peptides in amyloid plaques and hyperphosphorylated tau protein in intracellular as neurofibrillary tangles; neuronal loss; and impaired glucose metabolism. Due to a lack of effective prevention and treatment strategy, emerging evidence suggests that dietary and metabolic interventions could potentially target these issues. The ketogenic diet is a very high-fat, low-carbohydrate diet, which has a fasting-like effect bringing the body into a state of ketosis. The presence of ketone bodies has a neuroprotective impact on aging brain cells. Moreover, their production may enhance mitochondrial function, reduce the expression of inflammatory and apoptotic mediators. Thus, it has gained interest as a potential therapy for neurodegenerative disorders like Alzheimer’s disease. This review aims to examine the role of the ketogenic diet in Alzheimer’s disease progression and to outline specific aspects of the nutritional profile providing a rationale for the implementation of dietary interventions as a therapeutic strategy for Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Hypothesized mechanisms through which ketogenic diet (KD) influence Alzheimer’s disease (AD) development. ↓—decreased; ↑—increased. Based on Reference [7].](https://figures.cochat.ai/paper-figures/6eeba66bf29e4531a99920a01e1f15fc/ketogenic-diet-in-alzheimers-disease-figure-1.jpg)
![Figure 2 Hypothetical pathways leading to the neuroprotective action of KD (based on References [50,108]). FA—fatty acids; GABA—γ-aminobutyric acid; PCr:Cr—phosphocreatine:creatine ratio; ROS—reactive oxygen species; UCP—uncoupling proteins; increase (↑) or decrease (↓)—arrows indicate the direction of the relationship between variables.](https://figures.cochat.ai/paper-figures/bac5284128dd4da9b9753c793f254924/ketogenic-diet-in-alzheimers-disease-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, the neuroprotective effects of the ketogenic diet have also been reported in studies, which would benefit patients with Alzheimer’s or Parkinson’s disease [42,43].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 1×
“Cognitive deficits, resulting from the loss of neurons, are susceptible to neurofibrillary degeneration located in the limbic system, subcortical structures, archicortex and neocortex, and progressive synaptic dysfunction [4].”
BackgroundScheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., & Verdin, E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00038-8 · Cited by 1,536
Cahill, G. F. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111258 · Cited by 1,319
Jasper's Basic Mechanisms of the Epilepsies
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.001.0001 · Cited by 1,143
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.04.027 · Cited by 1,057
Hormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036
APP processing in Alzheimer’s disease.
Zhang, Y.-W., Thompson, R., Zhang, H., & Xu, H. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-3 · Cited by 983
Ketone bodies as signaling metabolites
Newman, J. C., & Verdin, E. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.002 · Cited by 966
Mitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806
Raina, P., Santaguida, P., Ismaila, A., Patterson, C., Cowan, D., Levine, M., Booker, L., & Oremus, M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00009 · Cited by 771
Monocarboxylate transporters in the central nervous system: distribution, regulation and function
Pierre, K., & Pellerin, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03168.x · Cited by 744
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689
An overview of APP processing enzymes and products.
Chow, V. W., Mattson, M. P., Wong, P. C., & Gleichmann, M. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8104-z · Cited by 684
Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G
Taggart, A. K. P., Kero, J., Gan, X., Cai, T.-Q., Cheng, K., Ippolito, M., Ren, N., Kaplan, R., Wu, K., Wu, T.-J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500213200 · Cited by 650
Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet
Bough, K. J., Wetherington, J., Hassel, B., Pare, J. F., Gawryluk, J. W., Greene, J. G., Shaw, R., Smith, Y., Geiger, J. D., & Dingledine, R. J. (2006) · Annals of Neurology · doi:10.1002/ana.20899 · Cited by 597
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies
Maalouf, M., Rho, J. M., & Mattson, M. P. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.09.002 · Cited by 574
Tissue-specific regulation of SIRT1 by calorie restriction
Chen, D., Bruno, J., Easlon, E., Lin, S.-J., Cheng, H.-L., Alt, F. W., & Guarente, L. (2008) · Genes & Development · doi:10.1101/gad.1650608 · Cited by 567
Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha
Chorley, B. N., Campbell, M. R., Wang, X., Karaca, M., Sambandan, D., Bangura, F., Xue, P., Pi, J., Kleeberger, S. R., & Bell, D. A. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks409 · Cited by 558
Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548
d -β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease
Kashiwaya, Y., Takeshima, T., Mori, N., Nakashima, K., Clarke, K., & Veech, R. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5440 · Cited by 535
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524 · cited 1×
“The altered glucose metabolism and mitochondrial function may result from the accumulation of advanced glycation end products (AGEs) [85].”
BackgroundAnticonvulsant Mechanisms of the Ketogenic Diet
Bough, K. J., & Rho, J. M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00915.x · Cited by 523
Effects of β-hydroxybutyrate on cognition in memory-impaired adults
Reger, M. A., Henderson, S. T., Hale, C., Cholerton, B., Baker, L. D., Watson, G. S., Hyde, K., Chapman, D., & Craft, S. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00087-3 · Cited by 508
NAD + metabolism: Bioenergetics, signaling and manipulation for therapy
Yang, Y., & Sauve, A. A. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.014 · Cited by 497
Verdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/105828 · Cited by 495
Neuroprotective and disease-modifying effects of the ketogenic diet
Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00009 · Cited by 445
Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, J. H., Heales, S. J. R., Walker, M. C., & Williams, R. S. B. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30408-8 · Cited by 440
The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders
Stafstrom, C. E., & Rho, J. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00059 · Cited by 438
Ketone Bodies, Potential Therapeutic Uses
Veech, R. L., Chance, B., Kashiwaya, Y., Lardy, H. A., & Cahill, G. F. (2001) · IUBMB Life · doi:10.1080/152165401753311780 · Cited by 429
The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages
Rahman, M., Muhammad, S., Khan, M. A., Chen, H., Ridder, D. A., Müller-Fielitz, H., Pokorná, B., Vollbrandt, T., Stölting, I., Nadrowitz, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms4944 · Cited by 427
The ketogenic diet increases mitochondrial uncoupling protein levels and activity
Sullivan, P. G., Rippy, N. A., Dorenbos, K., Concepcion, R. C., Agarwal, A. K., & Rho, J. M. (2004) · Annals of Neurology · doi:10.1002/ana.20062 · Cited by 411
De-Paula, V. J., Radanovic, M., Diniz, B. S., & Forlenza, O. V. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-5416-4_14 · Cited by 405
Huttenlocher, P. R. (1976) · Pediatric Research · doi:10.1203/00006450-197605000-00006 · Cited by 375
Kashiwaya, Y., Bergman, C., Lee, J.-H., Wan, R., King, M. T., Mughal, M. R., Okun, E., Clarke, K., Mattson, M. P., & Veech, R. L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.023 · Cited by 363 · cited 2×
“Rodents treated with the KD, exogenous β-OHB, and MCT display reduced brain Aβ levels, protection from amyloid-β toxicity, and improved mitochondrial function [10,30].”
BackgroundDietary ketosis enhances memory in mild cognitive impairment
Krikorian, R., Shidler, M. D., Dangelo, K., Couch, S. C., Benoit, S. C., & Clegg, D. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.006 · Cited by 361
Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress
Hori, Y. S., Kuno, A., Hosoda, R., & Horio, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073875 · Cited by 358
Kawai, Y., Garduño, L., Theodore, M., Yang, J., & Arinze, I. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208173 · Cited by 353
Plaque formation and the intraneuronal accumulation of β‐amyloid in Alzheimer's disease
Takahashi, R. H., Nagao, T., & Gouras, G. K. (2017) · Pathology International · doi:10.1111/pin.12520 · Cited by 346
Dietary and lifestyle guidelines for the prevention of Alzheimer's disease
Barnard, N. D., Bush, A. I., Ceccarelli, A., Cooper, J., de Jager, C. A., Erickson, K. I., Fraser, G., Kesler, S., Levin, S. M., Lucey, B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.033 · Cited by 339
The Role of Histone Acetylation in Memory Formation and Cognitive Impairments
Peixoto, L., & Abel, T. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.86 · Cited by 338
de la Monte, S. M. (2017) · Drugs · doi:10.1007/s40265-016-0674-0 · Cited by 331
Alzheimer's Disease and Mild Cognitive Impairment
Kelley, B. J., & Petersen, R. C. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.008 · Cited by 326
A ketogenic diet reduces amyloid beta 40 and 42 in a mouse model of Alzheimer's disease
Van der Auwera, I., Wera, S., Van Leuven, F., & Henderson, S. T. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-28 · Cited by 307
Brain aging, Alzheimer's disease, and mitochondria
Swerdlow, R. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.012 · Cited by 306 · cited 1×
“Moreover, patients with AD present mitochondrial dysfunction and metabolic changes, such as impaired glucose utilization in the brain (glucose hypometabolism) [5].”
BackgroundMcDaniel, S. S., Rensing, N. R., Thio, L. L., Yamada, K. A., & Wong, M. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.02981.x · Cited by 303
Role of ketogenic diets in neurodegenerative diseases (Alzheimer's disease and Parkinson's disease)
Włodarek, D. (2019) · Nutrients · doi:10.3390/nu11010169 · Cited by 301
Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study
VanItallie, T. B., Nonas, C., Di Rocco, A., Boyar, K., Hyams, K., & Heymsfield, S. B. (2005) · Neurology · doi:10.1212/01.wnl.0000152046.11390.45 · Cited by 300
Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice
Ma, D., Wang, A. C., Parikh, I., Green, S. J., Hoffman, J. D., Chlipala, G., Murphy, M. P., Sokola, B. S., Bauer, B., Hartz, A. M. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25190-5 · Cited by 299
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhao, Z., Lange, D. J., Voustianiouk, A., MacGrogan, D., Ho, L., Suh, J., Humala, N., Thiyagarajan, M., Wang, J., & Pasinetti, G. M. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-29 · Cited by 286
Ketogenic diets, mitochondria, and neurological diseases
Gano, L. B., Patel, M., & Rho, J. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r048975 · Cited by 277
Kim, D. Y., Hao, J., Liu, R., Turner, G., Shi, F.-D., & Rho, J. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035476 · Cited by 276
Ota, M., Matsuo, J., Ishida, I., Takano, H., Yokoi, Y., Hori, H., Yoshida, S., Ashida, K., Nakamura, K., Takahashi, T., et al. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.10.048 · Cited by 276
Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease
Taylor, M. K., Sullivan, D. K., Mahnken, J. D., Burns, J. M., & Swerdlow, R. H. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2017.11.002 · Cited by 272
Ułamek-Kozioł, M., Czuczwar, S. J., Januszewski, S., & Pluta, R. (2019) · Nutrients · doi:10.3390/nu11102510 · Cited by 266
Self-citationPinto, A., Bonucci, A., Maggi, E., Corsi, M., & Businaro, R. (2018) · Antioxidants · doi:10.3390/antiox7050063 · Cited by 259
Ageing, oxidative stress, and mitochondrial uncoupling
Harper, M. ‐., Bevilacqua, L., Hagopian, K., Weindruch, R., & Ramsey, J. J. (2004) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01370.x · Cited by 253
Cunnane, S. C., Courchesne‐Loyer, A., St‐Pierre, V., Vandenberghe, C., Pierotti, T., Fortier, M., Croteau, E., & Castellano, C. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12999 · Cited by 250
Sinha, S. R., & Kossoff, E. H. (2005) · The Neurologist · doi:10.1097/01.nrl.0000160818.58821.d2 · Cited by 245
The ketogenic diet increases mitochondrial glutathione levels
Jarrett, S. G., Milder, J. B., Liang, L., & Patel, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05460.x · Cited by 244
β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms
Achanta, L. B., & Rae, C. D. (2017) · Neurochemical Research · doi:10.1007/s11064-016-2099-2 · Cited by 237
Amyloid precursor protein processing and bioenergetics
Wilkins, H. M., & Swerdlow, R. H. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.009 · Cited by 223
Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases
Paoli, A., Bianco, A., Damiani, E., & Bosco, G. (2014) · BioMed Research International · doi:10.1155/2014/474296 · Cited by 220
Otto, C., Kaemmerer, U., Illert, B., Muehling, B., Pfetzer, N., Wittig, R., Voelker, H. U., Thiede, A., & Coy, J. F. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-122 · Cited by 213
Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet
Milder, J. B., Liang, L.-P., & Patel, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.030 · Cited by 212
Ketogenic diet exhibits anti‐inflammatory properties
Dupuis, N., Curatolo, N., Benoist, J., & Auvin, S. (2015) · Epilepsia · doi:10.1111/epi.13038 · Cited by 210
Ketone Bodies in Neurological Diseases: Focus on Neuroprotection and Underlying Mechanisms
Yang, H., Shan, W., Zhu, F., Wu, J., & Wang, Q. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00585 · Cited by 199
McNally, M. A., & Hartman, A. L. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07670.x · Cited by 194
A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease
Newport, M. T., VanItallie, T. B., Kashiwaya, Y., King, M. T., & Veech, R. L. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.01.006 · Cited by 192
Long-term effects of a ketogenic diet in obese patients.
Dashti, H. M., Mathew, T. C., Hussein, T., Asfar, S., Behbahani, A. I., Khoursheed, M., Al-Sayer, H. M., Bo-Abbas, Y. Y., & Al-Zaid, N. S. (2004) · PubMed · Cited by 191
Genetics of Alzheimer's Disease
Guerreiro, R. J., & Hardy, J. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0295-9 · Cited by 190
Ketone bodies mediate antiseizure effects through mitochondrial permeability transition
Kim, D. Y., Simeone, K. A., Simeone, T. A., Pandya, J. D., Wilke, J. C., Ahn, Y., Geddes, J. W., Sullivan, P. G., & Rho, J. M. (2015) · Annals of Neurology · doi:10.1002/ana.24424 · Cited by 189
Diet-induced hypercholesterolemia enhances brain Aβ accumulation in transgenic mice
Shie, F.-S., Jin, L.-W., Cook, D. G., Leverenz, J. B., & LeBoeuf, R. C. (2002) · Neuroreport · doi:10.1097/00001756-200203250-00019 · Cited by 184
Mondragón‐Rodríguez, S., Perry, G. L., Zhu, X., Moreira, P. I., Acevedo, M., & Williams, S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/940603 · Cited by 184
Modulation of oxidative stress and mitochondrial function by the ketogenic diet
Milder, J., & Patel, M. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.09.021 · Cited by 181
Castellano, C.-A., Nugent, S., Paquet, N., Tremblay, S., Bocti, C., Lacombe, G., Imbeault, H., Turcotte, É., Fulop, T., & Cunnane, S. C. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-141074 · Cited by 176
Brownlow, M. L., Benner, L., D’Agostino, D. P., Gordon, M. N., & Morgan, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075713 · Cited by 170
Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester
Hashim, S. A., & VanItallie, T. B. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046599 · Cited by 167
Hypometabolism as a therapeutic target in Alzheimer's disease
Costantini, L. C., Barr, L. J., Vogel, J. L., & Henderson, S. T. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s16 · Cited by 162 · cited 2×
“Energy deficiency may be observed in different brain structures, especially in the hippocampus [29].”
BackgroundNeuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity
Yang, X., & Cheng, B. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9336-y · Cited by 158
The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease
Broom, G. M., Shaw, I. C., & Rucklidge, J. J. (2018) · Nutrition · doi:10.1016/j.nut.2018.10.003 · Cited by 151
Neuroketotherapeutics: A modern review of a century-old therapy
Koppel, S. J., & Swerdlow, R. H. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.019 · Cited by 150
Ketogenic Diets for Adult Neurological Disorders
McDonald, T. J. W., & Cervenka, M. C. (2018) · Neurotherapeutics · doi:10.1007/s13311-018-0666-8 · Cited by 148
Response of brain amino acid metabolism to ketosis
Yudkoff, M., Daikhin, Y., Nissim, I., Horyn, O., Lazarow, A., Luhovyy, B. L., Wehrli, S. L., & Nissim, I. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.014 · Cited by 146
A high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults
Taylor, M. K., Sullivan, D. K., Swerdlow, R. H., Vidoni, E. D., Morris, J. K., Mahnken, J. D., & Burns, J. M. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.162263 · Cited by 146
Zhang, J., Cao, Q., Li, S., Lu, X., Zhao, Y., Guan, J., Chen, J., Wu, Q., & Chen, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.043 · Cited by 140
Yao, J., Rettberg, J. R., Klosinski, L. P., Cadenas, E., & Brinton, R. D. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.005 · Cited by 140
Sah, S. K., Lee, C. M., Jang, J., & Park, G. H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.122 · Cited by 135
High fat diet exacerbates Alzheimer's disease-related pathology in APPswe/PS1 mice
Thériault, P., ElAli, A., & Rivest, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12179 · Cited by 133
The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders
Cullingford, T. E. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.09.008 · Cited by 124
Ketogenic diet treatment in adults with refractory epilepsy
Klein, P., Janousek, J., Barber, A., & Weissberger, R. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.09.016 · Cited by 120
Pawlosky, R. J., Kemper, M. F., Kashiwaya, Y., King, M. T., Mattson, M. P., & Veech, R. L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13958 · Cited by 108
Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism?
Elamin, M., Ruskin, D. N., Masino, S. A., & Sacchetti, P. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00377 · Cited by 105
Beckett, T. L., Studzinski, C. M., Keller, J. N., Murphy, M. P., & Niedowicz, D. M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.046 · Cited by 103
The Contribution of Ketone Bodies to Basal and Activity-Dependent Neuronal Oxidation in Vivo
Chowdhury, G. M. I., Jiang, L., Rothman, D. L., & Behar, K. L. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.77 · Cited by 103
Rebello, C. J., Keller, J. N., Liu, A. G., Johnson, W. D., & Greenway, F. L. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.01.001 · Cited by 99
The Expanding Role of Ketogenic Diets in Adult Neurological Disorders
McDonald, T. J. W., & Cervenka, M. C. (2018) · Brain Sciences · doi:10.3390/brainsci8080148 · Cited by 98
Vinciguerra, F., Graziano, M., Hagnäs, M. P., Frittitta, L., & Tumminia, A. (2020) · Nutrients · doi:10.3390/nu12041019 · Cited by 97
Omar, S. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112797 · Cited by 87
George, A. J., Holsinger, R. M. D., McLean, C., Laughton, K. M., Beyreuther, K. T., Evin, G. M., Masters, C. L., & Li, Q. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.009 · Cited by 84
Studzinski, C. M., MacKay, W. A., Beckett, T. L., Henderson, S. T., Murphy, M. P., Sullivan, P. G., & Burnham, W. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.005 · Cited by 83
Ohnuma, T., Toda, A., Kimoto, A., Takebayashi, Y., Higashiyama, R. I., Tagata, Y., Ito, M., Ota, T., Shibata, N., & Arai, H. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s95362 · Cited by 83
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R. S. J., & Schroeter, M. L. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.07.005 · Cited by 77
How Can a Ketogenic Diet Improve Motor Function?
Veyrat‐Durebex, C., Reynier, P., Procaccio, V., Hergesheimer, R. C., Corcia, P., Andres, C. R., & Blasco, H. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00015 · Cited by 76
Taylor, M. K., Swerdlow, R. H., Burns, J. M., & Sullivan, D. K. (2019) · Current Developments in Nutrition · doi:10.1093/cdn/nzz003 · Cited by 73
Torosyan, N., Sethanandha, C., Grill, J. D., Dilley, M., Lee, J., Cummings, J. L., Ossinalde, C., & Silverman, D. H. S. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.009 · Cited by 67
Diet-Induced Ketosis Improves Cognitive Performance in Aged Rats
Xu, K., Sun, X., Eroku, B. O., Tsipis, C. P., Puchowicz, M. A., & LaManna, J. C. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1241-1_9 · Cited by 63
Nafar, F., Clarke, J.-P. W. E., & Mearow, K. M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.008 · Cited by 63
Lysine Deacetylases Regulate the Heat Shock Response Including the Age-Associated Impairment of HSF1
Zelin, E., & Freeman, B. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.02.010 · Cited by 61
Winiarska‐Mieczan, A., Baranowska‐Wójcik, E., Kwiecień, M., GRELA, E. R., Szwajgier, D., Kwiatkowska, K., & Kiczorowska, B. (2020) · Nutrients · doi:10.3390/nu12020435 · Cited by 61
Ketogenic diets and Alzheimer’s disease
Lange, K. W., Lange, K. M., Makulska-Gertruda, E., Nakamura, Y., Reissmann, A., Kanaya, S., & Hauser, J. (2017) · Food Science and Human Wellness · doi:10.1016/j.fshw.2016.10.003 · Cited by 56
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Yao, J., & Brinton, R. D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072517 · Cited by 55
Lee, J., Kim, S. J., Son, T. G., Chan, S. L., & Mattson, M. P. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20831 · Cited by 53
VanItallie, T. B. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.024 · Cited by 47
Lauritzen, K. H., Hasan‐Olive, M. M., Regnell, C. E., Kleppa, L., Scheibye‐Knudsen, M., GJEDDE, A. H., Klungland, A., Bohr, V. A., Storm‐Mathisen, J., & Bergersen, L. H. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.005 · Cited by 42
To treat or not to treat drug-refractory epilepsy by the ketogenic diet? That is the question
Ułamek-Kozioł, M., Pluta, R. M., Bogucka‐Kocka, A., & Czuczwar, S. J. (2016) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1226841 · Cited by 29
Self-citationŻarnowski, T., Tulidowicz-Bielak, M., Kosior‐Jarecka, E., Żarnowska, I., Turski, W. A., & Ga̧sior, M. (2012) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 20
The ketogenic diet for epilepsy therapy in children: Quo vadis?
Pluta, R. M., & Jabłoński, M. (2011) · Nutrition · doi:10.1016/j.nut.2010.12.015 · Cited by 18
Self-citation
Cited by
ApoE in Alzheimer’s disease: pathophysiology and therapeutic strategies
Raulin, A.-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C.-C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00574-4 · Cited by 756
Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases
Jensen, N. J., Wodschow, H. Z., Nilsson, M., & Rungby, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228767 · Cited by 446
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 399
Ułamek-Kozioł, M., Czuczwar, S. J., Januszewski, S., & Pluta, R. (2019) · Nutrients · doi:10.3390/nu11102510 · Cited by 266
Self-citationChallenges and hopes for Alzheimer’s disease
Tatulian, S. A. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.016 · Cited by 291
Metadata
- Authors
- Rusek, M., Pluta, R., Ułamek-Kozioł, M., & Czuczwar, S. J.
- Affiliations
- Medical University of Lublin (PL)
- Mossakowski Medical Research Institute, Polish Academy of Sciences (PL)
- Institute of Psychiatry and Neurology (PL)
- Corresponding author
- Pluta, Ryszard
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-08-09
- Volume
- 20
- Issue
- 16
- Pages
- 3892
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6720297
- OpenAlex
- W2968152726
- Cited by
- 319
- References
- 124
- Citations by year
- 2026: 21 · 2025: 39 · 2024: 52 · 2023: 63 · 2022: 65 · 2021: 49 · 2020: 25 · 2019: 3
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Uniwersytet Medyczny w Lublinie
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- ketogenic diet, Alzheimer's disease, ketone bodies, neuroprotection, amyloid plaques, tau hyperphosphorylation, neurofibrillary tangles, mitochondrial function, neuroinflammation, apoptosis, dietary intervention, glucose metabolism
- MeSH terms
- Neuroprotection, Alzheimer Disease, Animals, Humans, Amyloid beta-Peptides, tau Proteins, Diet, Ketogenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.